Warning letter
Kumato Labs: warning letter of Feb 3, 2017
FDA warning letter 510068 · Los Angeles District Office
Key facts
| Reference number | 510068 |
|---|---|
| Company | Kumato Labs |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Feb 3, 2017 |
| Posted date | Feb 14, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.553, 111, 111.55, 111.105, 111.453, 111.70(f), 111.127(h), 111.570(b)(2) |
| Inspection city | Signal Hill |
| Inspection ZIP | 90755 |
| Inspection start date | Aug 31, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- NAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: